RETEPLASE News
RETEPLASE currently has 2 news articles, with 14 predicted indications.
This page combines the AI-predicted indications for RETEPLASE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (14):
- myocardial infarction (99.0%)
- coronary thrombosis (99.0%)
- hemoglobinopathy (99.0%)
- myocardial infarction (disease) (99.0%)
- posterolateral myocardial infarction (99.9%)
- posteroinferior myocardial infarction (99.9%)
- septal myocardial infarction (99.9%)
- congenital coronary artery anomaly (99.8%)
- coronary stenosis (99.6%)
- heparin cofactor 2 deficiency (99.5%)
- partial deletion of the short arm of chromosome 16 (99.3%)
- beta-thalassemia with other manifestations (99.3%)
- antithrombin deficiency type 2 (99.2%)
- hemolytic anemia due to glucophosphate isomerase deficiency (99.2%)
Related News (2)
From wrist to research: Harnessing smartwatch data for equitable cardiovascular research
2026-09-28 cardiovascular
Source: journals.plos.org
Conference MDAngle: HFSA 2026 Amyloidosis/ATTR-CM
2026-09-28 heart disease
Source: Medscape
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.